ABSTRACT
Introduction
Epilepsy is one of the most frequent neurological diseases characterized by repeated unprovoked seizures that affect over 50 million people worldwide or approximately 1-2 in 100 human (Hauser, 1994) . Antiepileptic drugs (AEDs) are frequently used to restrain and block epileptic seizures but these drugs may cause several side effects (Lagae, 2006) . Common adverse effects are reduced attention, motor slowing and moderate memory impairment (Meador et al., 2005) . Cognitive and behavioral failures are more common in epileptic patients than in the general population. Seizure-induced impairment of cognitive function in epilepsy patients may result from cell damage in specific brain areas related to learning and memory, as well as from epileptiform activity in the brain (Lynch et al., 1996) . Notwithstanding that epilepsy can induce learning and memory dysfunctions, the probable contribution of ADEs to these dysfunctions may describe a significant topic in the treatment of patients with epilepsy who are using drugs for a long time (Mula and Trimble, 2009 ). Cognitive adverse effects of AEDs are especially important for children than adults (Kuzniecky and Mortati, 2005) . Therefore, determining the effects of antiepileptic drugs on cognitive function in individuals with epilepsy is very important with respect to quality of life for patients.
Actually, in spite of AEDs-induced epilepsy restraint can rehabilitate memory; chronic application of AEDs may cause memory impairments. It has been demostrated in a clinical study that valproate (VPA) causes significant impairments in hypothetical thinking, imaginativeness, memory, and mathematic reasoning in patients (Straussberg et al., 1998) . VPA was also displayed to impair spatial working memory in rats (Umka et al., 2010) . On the other hand, some studies suggest that second-generation AEDs do not unfavorably affect cognitive function like levetiracetam (LEV), oxcarbazepine (OXC) and lamotrigine (LTG) (Lagae, 2006; Donati et al., 2007) . Topiramate (TPM) is also a second-generation ADEs and it has been associated with particular side effects on memory in children (Coppola et al., 2008) . However there are some experimental and clinical studies available which suggest that TPM application has no adverse effects on memory (PerezAlvarez et al., 2006; Nowakowska et al., 2009 ). According to the literature, the effects of AEDs on learning and memory functions in patients with epilepsy are controversial.
Animal models of learning and memory provides a useful approach for examining the possible effect of AEDs on cognitive functions (Lamberty et al., 2000) . To date, there have been no studies investigating and comparing the effects of the first and second generation ADEs on passive avoidance learning and memory in prepubertal non-epileptic rats. Therefore, we aimed to evaluate and compare the effects of chronic treatment with VPA, carbamazepine (CBZ), LEV, OXC, LTG and TPM in male and female rats at postnatal day 21 on a step-through passive avoidance task, which is considered to be simple and reliable examination of learning and memory. We also aimed to test whether the first and second generation ADEs have diverse effects on gender differences in young rats.
Materials and methods Animals
Sixty male and forty-nine female pre-pubertal Sprague Dawley rats, 21days old and weighing between 41-53 g, were obtained from Karadeniz Technical University Medical Faculty Animal Laboratory and used in this study. Animals were housed under a 12:12 h light-dark cycle (light on at 07:00h) and room temperature of 20±2°C. There were no specific restrictions in the diet content and amount administered to the animals in our study. They were given free access to food and water. The controls and drug-administered groups consumed the same food and water. Each application was made to minimize animal suffering and the number of animals used. Experimental procedures were carried out in accordance with the European Communities Council Directive of 24 November 1986 (86/609/EEC) and were approved by the Animal Experimentation Ethics Committee of Karadeniz Technical University.
Experimental design and drug administration
Male and female rats were divided into 7 groups. Total of 60 male and 49 female rats were into the following experimental groups: (1) the control group was given tap water by oral gavage; (2) the VPA groups was given 300 mg/kg/day of VPA (Depakin®; Sanofi Dogu, Istanbul, Turkey); (3) the CBZ group was given 150 mg/kg/day of CBZ (Tegretol®, Novartis, Istanbul, Turkey); (4) the LEV group was given 50 mg/ kg/day of LEV (Vetria®, Biofarma, Istanbul, Turkey) (5) the OXC group was given 150 mg/kg/day of OXC (Trileptal®, Novartis, Istanbul, Turkey); (6) the LTG group was given 10 mg/kg/day of LTG (Lamictal®, Glaxo Smithkline, Istanbul, Turkey); (7) the TPM group was given 100 mg/kg/day of TPM (Topamax®, Johnson & Johnson, Istanbul, Turkey) . Antiepileptic drugs were given in the tap water. The doses of drugs in the treatment groups were defined according to the weights of rats. VPA, CBZ, LEV, OXC, LTG and TPM doses were adopted from literature (Lim and Miller, 1997; Otoom et al., 2004; Cansu et al., 2008; Svalheim et al., 2008) . All drugs were administered for 21 days at 12h intervals in 2 doses via oral gavage (Fig. 1) .
Passive avoidance apparatus
The passive avoidance apparatus consisted of two adjoining compartments, a dark chamber (20×20×20 cm) with black walls and a light chamber (20×10×10 cm) with transparent walls. The dark chamber is connected with a light chamber via a guillotine door with dimensions of 5×7 cm. The light chamber was made of a transparent material that was illuminated by a 60 W light bulb located 50 cm above the floor. The floor of each compartment consisted of a stainless steel grid with a grid spacing of 1 cm and 3 mm in diameter located at 2 cm above the base of the chamber. The dark compartment contained steel rods capable of delivering an electric shock to the animal's feet. The electroshock apparatus capable of producing a current of 1.5 mA for any desired time was connected to a grid for delivering footshocks.
Passive avoidance procedure
To measure the ability of rats to remember a footshock delivered 24 h earlier, a two-compartment enclosure with shockgrid floor was used. This experiment was carried out as described previously (Yildirim and Marangoz, 2004) . On the day of the learning trial, rats were placed in the light chamber of passive avoidance apparatus. The sliding door separating the light and dark chambers was removed 3 sec after the placement of the animals. Chronometer was started once the sliding door was completely lifted. Avoidance latency to enter the dark chamber was recorded. Spontaneous behaviors of animals were also assessed such as the total number of head-pokes (head, including ears). After the animal fully passed the gate and entered the dark chamber, a footshock of 1.5 mA lasting 3 sec was applied to the animal (the learning trial) by the sliding door separating the compartments was closed. Both chambers of the apparatus were cleaned after each rat to remove any confounding olfactory signals. After 24h, rats were placed in the light chamber again and observed for 300s (the test trial). The time delay between the full-body entrances from the light chamber to the dark chamber in the test trial was recorded as the avoidance latency. This latency is a fundamental indicator of memory formation; the shorter the latency, the weaker the memory (Fig. 1) .
Statistics
Avoidance latency was expressed as mean±SEM. After the data analyzed via Kruskal Wallis analysis of variance, significance between groups was tested using the Mann-Whitney U test. P values that was less than smaller than 0.05 were considered statistically significant. Fig. 1 . Schematic explanation of the experimental protocol used in present study. Sixty male and forty-nine female pre-pubertal Sprague Dawley rats, 21days old and weighing between 41-53 g, were used in this study. Male and female rats were divided into 7 groups. VPA, CBZ, LEV, OXC, LTG and TPM were administered for 21 days at 12-h intervals in 2 doses via oral gavage.
Results
We determined the effects of first-and second-generation AEDs on the passive-avoidance response in male and female prepubertal rats. A dose of ADEs was given orally 2h before the training trial. There were no significant differences in training latencies between ADEs groups with their control groups as shown in Table 1 . Mean training latencies for male and female rats were 16±3 and 19±4 sec, respectively.
The last dose of ADEs was given orally 2h before the retention trial which was carried out the day after the training trial. The test was repeated 24h later in the retention trial Kruskal-Wallis test displayed that chronic ADEs treatment did not influence the avoidance latencies with respect to their control group (Table 2,3). In male control rats, the avoidance latency in the retention trial was 273±16 sec., whereas the step-through latency in the training trial was 13±1 sec. in female control rats, the avoidance latency in the retention trial was 266±31 sec similarly, whereas the step-through latency in the training trial was 15±2 sec. This is clearly indicating that both male and female rats had obtained the passive-avoidance response. In male rats, mean avoidance latencies for 300 mg/ kg VPA, 150 mg/kg CBZ, 50 mg/kg LEV, 150 mg/kg OXC, 10 mg/kg LTG and 100 mg/kg TPM were 300±0, 242±31, 125±45, 278±22, 267±32 and 293±6 sec, respectively. There were no significant differences between ADEs groups and control group (Table 2, 3). 50 mg/kg LEV administration decreased the avoidance latency but the difference was not statistically significant when compared to controls. In female rats, mean avoidance latencies for 300 mg/kg VPA, 150 mg/ kg CBZ, 50 mg/kg LEV, 150 mg/kg OXC, 10 mg/kg LTG and 100 mg/kg TPM were 146±40, 300±0, 268±31, 234±38, 197±41 and 300±0 sec., respectively. There were also no significant differences between ADEs groups and control group in female rats (Table 2, 3). 300 mg/kg VPA reduced the avoidance latency but the difference was not statistically significant when compared to control rats. We finally compared the performances between male and female groups that received the same drug. Interestingly, in VPA and LEV groups there were significant differences (p<0.001 and p=0.028 respectively) (Fig. 2) .
Discussion
In the present study, we tested the hypothesis that secondgeneration antiepileptic drugs (LEV, OXC, LTG, TPM) are less likely to cause cognitive side effects than first-generation antiepileptic drugs (VPA, CBZ) in prepubertal rats. A secondary objective in the current study was to determine whether there were any cognitive differences between male and female rats. Until now, no information regarding cognitive effects of Fig. 2 . Passive avoidance performances of the experimental groups. In valproic acid and levetiracetam groups, the sexually dimorphic performances were observed. The cognitive function of VPA received females and LEV received males were significantly reduced compared to the opposite sex that received the same drugs. Values are mean±SEM. After the data analyzed via Kruskal Wallis analysis of variance, significance between groups was tested using the Mann-Whitney U test first-and second-generation ADEs application in male and female rats during the prepubertal period were available. The passive avoidance test is useful for assessing memory reductions in response to many pharmacological agents (Yildirim and Marangoz, 2004) . After our testing we determined that traditional antiepileptic drugs VPA and CBZ did not cause any cognitive changes as compared with control. When the traditional antiepileptic drugs were compared with the new antiepileptic drugs, there were no significant differences in passive avoidance latencies. Presently, our findings showed that in a passive avoidance paradigm learning and memory performance are not impaired by chronic administration of first-and second-generation AEDs during the prepubertal period. Antiepileptic treatment may decrease the mental and behavioral defects by blocking or lessening the epileptic seizures, but AEDs may also cause unpleasant effects on cognitive functions (Seo et al., 2007) . VPA is widely used with a broad spectrum of activity against both generalized and partial epilepsy. It has been usually utilized for the restraint of the neuronal over-excitation by increasing the levels of GABA and the activity of glutamic acid decarboxylase and also via the blockage of voltage-sensitive sodium channels (McLean and Macdonald, 1986) . Powerful anti-epileptic properties of VPA, as well as to affect cognitive function, have been reported in the literature with increasing frequency. However, it is still not clear whether VPA has a positive or negative effect on cognitive functions. It has been notified that VPA can impair learning and memory processes both in the experimental models and patients with epilepsy (Yochum et al., 2008; Mula and Trimble, 2009) . Several reports have documented the mild/moderate cognitive defects in adult patients treated with VPA (Carpay et al., 2005) . Cognitive capabilities were also normalized when VPA was discontinued (Lossius et al., 2008) .
A recent study showed that VPA can cause cognitive deterioration in adult male Lister Hooded rats which are connected with changes in hippocampal neurogenesis and neurotrophin levels (Umka et al., 2010) . In contrast to these studies, Sirén and co-worker showed that visual memory and delicate motor continuity were enhanced in children treated with VPA (Sirén et al. 2007) . TPM is a newer AED, which is widely used for infantile spasms and complex partial seizures in children. It was reported that 20 mg/kg TPM but not 100 mg/kg TPM significantly reduced short-term memory deficits on Morris water maze performance in rats with pilocarpine-induced status epilepticus. While neuroprotective effects of 100 mg/kg TPM were observed in hippocampal CA area, cell loss after application of 20 mg/kg TPM was indiscernible from group receiving diazepam only (Frisch et al., 2007) . Little is known as yet about the influences of LEV, another new antiepileptic drug, on learning and memory functions. An experimental study reported that LEV has been stated to have beneficial cognitive effects in a scopolamine-induced amnesia model in mice and in water-maze task in rats (Zhou et al., 2007) .
Limited studies have compared second-generation AEDs to traditional AEDs but several reports have suggested that newer AEDs such as lamotrigine, topiramate and gabapentin may have less effects on cognitive functions than conventional AEDs drugs (Martin et al., 1999) . Second-generation AEDs appear to be more positive than the traditional drugs with respect to adverse cognitive effects (Aldenkamp et al., 2003) . For instance, cognitive performance in the Morris water maze test was not changed by the doses of LEV (17-54-170 mg/kg) known to suppress motor seizures in normal and amygdala-kindled rats. In contrast, higher doses of VPA (200-300 mg/kg), CZP (0.3-1 mg/kg), and CBZ (40-60 mg/ kg) decreased learning performance of both non-epileptic and kindled epileptic rats (Lamberty et al., 2000) . Recently, a non-interventional study shows that compared with CBZ, LEV has slightly but absolutely superior effects on cognition in both pretreated and non-pretreated patients (Helmstaedter and Witt, 2010) . In studies comparing the adverse effects of LTG with other AEDs on cognitive function in healthy volunteers have showed fewer side effects for LTG than for CBZ, VPA and TPM (Meador et al., 2001; Meador et al., 2005) . A retrospective study also showed that LTG and OXC monotherapies in epilepsy patients have similar positive cognitive effects (Seo et al., 2007) .
In the present study we have observed a sexual dimorphism in the effects of VPA and LEV. The cognitive function of VPA received females and LEV received males were significantly reduced compared to the opposite sex that received the same drugs. The sex dependent differeces in cognitive functions are well documented (Kanit et al., 2003; Rücker et al., 2004) . Brain responses to environmental or psychological stimuli may differ between genders (Dalla et al., 2008; Harte and Dow-Edwards, 2010 ). In our study, it can be proposed that LEV and VPA affected the learning performance by a mechanism that expressed differently between genders. To clarify how these two antiepileptic drugs affect the cognitive performance in a sexually dimoprhic way further behavioral and mechanistic studies are necessary.
Investigation of potential side effects of AEDs on learning and memory in non-epileptic animals may be helpful for safe and effective medication in people with epilepsy, especially young people with epilepsy. It has been widely reported in the literature that antiepileptic drugs (AEDs) can cause cognitive side effects (Aldenkamp et al., 2003) . But in the present study there were no significant effects of AEDs on learning parameter in young rats. Our results show that chronic administration of first-(VPA, CBZ) and second-generation (LEV, OXC, LTG, TPM) AEDs did not prevent the learning of the passive-avoidance response and memory formation for both male and female prepubertal rats. In conclusion, the present findings offer evidence that the long-term use of traditional or new ADEs do not impair cognitive performance in young male and female rat, at least at the doses used in this study.
